Companies / ACADIA Pharmaceuticals Inc
ACADIA Pharmaceuticals Inc
Insider flow · last 90 daysNet sells $412.3K
Financials · FY2025
Ownership
172.3M shares outstanding · as of Jul 28, 2026
Ownership
| Insiders | 23.01% | 39,640,088 |
| 10%+ / strategic | 10.36% | 17,857,219 |
| Institutions | 67.58% | 116,445,518 |
| Public float | 0.00% | 0 |
Reported holdings exceed shares outstanding — public float shown as 0; some positions may overlap or lag.
% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.
Insiders 18
View all →| Insider | % of shares | Shares |
|---|---|---|
Baker Bros. Advisors LPDirector · 10% owner | 22.86% | 39,384,587 |
Schneyer Mark C.EVP, CHIEF FINANCIAL OFFICER | 0.04% | 66,145 |
Harrigan EdmundDirector | 0.03% | 43,148 |
Garofalo Elizabeth a.Director | 0.02% | 33,489 |
Ndu AdoraDirector | 0.02% | 32,908 |
Brege LauraDirector | 0.01% | 23,202 |
Owen Adams CatherineCEOChief Executive Officer · Director | <0.01% | 14,803 |
Kihara JamesPRINCIPAL ACCOUNTING OFFICER | <0.01% | 13,088 |
Daly James MDirector | <0.01% | 12,148 |
Rhodes Jennifer JEVP, CHIEF LEGAL OFFICER, SEC | <0.01% | 11,280 |
Institutional holders 342
View all →| Holder | Value | % of shares |
|---|---|---|
| $954.88M | 24.90% | |
| $569.63M | 13.07% | |
| $404.76M | 8.79% | |
| $229.63M | 5.27% | |
| $190.83M | 4.15% | |
| $90.21M | 1.96% | |
| $78.02M | 1.70% | |
| $77.14M | 2.01% | |
| $74.43M | 1.94% | |
| $63.95M | 1.67% |
Activity
Jun 30, 2026View all →
InsidersInstitutions
Who's accumulating and trimming this stock (13F).| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Q2 2026 as of | BlackRock, Inc. 13F manager | Add | Common stock | $44.52M | +1.8M +8.48% | 22,515,173 13.07% of shares | medium |
| Q1 2026 as of | Norges Bank 13F manager | Exit | Common stock | $-40.27M | -1.5M -100.00% | 0 | medium |
| Q2 2026 as of | State Street Corporation 13F manager | Add | Common stock | $29.49M | +1.2M +14.73% | 9,076,212 5.27% of shares | medium |
| Q1 2026 as of | First Trust Advisors LP 13F manager | Add | Common stock | $23.90M | +1.1M +47.30% | 3,343,868 1.94% of shares | medium |
| Q1 2026 as of | Emerald Advisers, LLC 13F manager | Trim | Common stock | $-17.42M | -783K -96.47% | 28,637 0.02% of shares | medium |
| Q2 2026 as of | Deutsche Bank AG 13F manager | Trim | Common stock | $-14.44M | -571K -68.89% | 257,759 0.15% of shares | medium |
| Q1 2026 as of | Emerald Mutual Fund Advisers Trust 13F manager | Trim | Common stock | $-10.42M | -468K -96.58% | 16,576 <0.01% of shares | medium |
| Q1 2026 as of | Marshall Wace, LLP 13F manager | Trim | Common stock | $-9.29M | -417K -84.56% | 76,187 0.04% of shares | medium |
5%+ ownership events
Schedule 13D / 13G
| Filer | Stance | % of class |
|---|---|---|
| Vanguard Group Inc | Passive13G/A | — |
| State Street Corporation | Passive13G | — |
| Vanguard Portfolio Management | Passive13G | — |
Securities
via CUSIP / OpenFIGI
| Symbol | Type | CUSIP |
|---|---|---|
| ACAD | — | 004225108 |